These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11952979)

  • 41. Technical aspects of nuchal translucency measurement.
    Abuhamad A
    Semin Perinatol; 2005 Dec; 29(6):376-9. PubMed ID: 16533650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcome for children born after a first-trimester measurement of increased nuchal translucency with a normal karyotype: a retrospective analysis.
    Axt-Fliedner R; Hartge D; Chiriac A; Krapp M; Berg C; Geipel A; Germer U; Gembruch U
    Ultraschall Med; 2009 Dec; 30(6):558-63. PubMed ID: 19137496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
    Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
    Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First-trimester ultrasound screening for chromosomal defects.
    Snijders RJ; Johnson S; Sebire NJ; Noble PL; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Mar; 7(3):216-26. PubMed ID: 8705419
    [No Abstract]   [Full Text] [Related]  

  • 45. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
    Lam YH; Tang MH; Lee CP; Tse HY
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enlarged nuchal translucency and low serum protein concentrations as possible markers for Zellweger syndrome.
    de Graaf IM; Pajkrt E; Keessen M; Leschot NJ; Bilardo CM
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):268-70. PubMed ID: 10341407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
    Bronshtein M; Zimmer EZ; Blazer S
    Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two-stage ultrasonography in screening for fetal anomalies at 13-14 and 18-22 weeks of gestation.
    Taipale P; Ammälä M; Salonen R; Hiilesmaa V
    Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1141-6. PubMed ID: 15548146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.
    Schaefer M; Laurichesse-Delmas H; Ville Y
    Ultrasound Obstet Gynecol; 1998 Apr; 11(4):271-3. PubMed ID: 9618851
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuchal translucency in normal fetuses in a Thai population.
    Panburana P; Jaovisidh A; Ajjimakorn S; Tungkajiwangoon P
    J Med Assoc Thai; 2002 Feb; 85(2):245-9. PubMed ID: 12081126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation.
    Galindo A; Comas C; Martínez JM; Gutiérrez-Larraya F; Carrera JM; Puerto B; Borrell A; Mortera C; de la Fuente P
    J Matern Fetal Neonatal Med; 2003 Mar; 13(3):163-70. PubMed ID: 12820838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrasound screening for fetal abnormalities in the first trimester.
    Chitty LS; Pandya PP
    Prenat Diagn; 1997 Dec; 17(13):1269-81. PubMed ID: 9509545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuchal translucency.
    Blakemore KJ
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):388-90. PubMed ID: 9674083
    [No Abstract]   [Full Text] [Related]  

  • 57. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality.
    van Vugt JM; van Zalen-Sprock RM; Kostense PJ
    Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between fetal nuchal translucency and crown-rump length in an Asian population.
    Jou HJ; Wu SC; Li TC; Hsu HC; Tzeng CY; Hsieh FJ
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):111-4. PubMed ID: 11251917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.